News blog

Ranbaxy ‘falsified drug approval data’, says FDA

The US Food and Drug Administration has accused India-based drug manufacturer Ranbaxy of falsifying data in both approved and pending drug applications.

BACK TO ARTICLE

Tell a Friend

Please ensure that your friend is content to receive an email from us with a link to the article. Select the following link to view our Privacy Policy.

BACK TO ARTICLE